Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-26 @ 1:05 AM
Study NCT ID:
NCT04689659
Status:
COMPLETED
Last Update Posted:
2025-05-18
First Post:
2020-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma
Sponsor:
Beijing Boren Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-28
First Submit QC Date:
None
Study First Post Date:
2020-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-14
Last Update Post Date:
2025-05-18
Last Update Post Date Type:
ACTUAL